Adrienne L Graves
CIK 1326192 · last filed 2026-06-22
Adrienne L Graves is a corporate insider who has filed 52 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for HROW, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$361.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $452.3K across reported positions. 6 SEC filings were submitted jointly with HARROW HEALTH, INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
AKRX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
NAPA, CA 94558
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HROW | Director | 1,000 | $29.24 | $29.2K | $31.1K | 2 | 2026-06-22 |
| OCUL | Director | 64,000 | $6.61 | $423.0K | $0 | 4 | 2026-06-12 |
| Opus Genetics, Inc. (OCUP) Delisted | Director | 127,514 | $1.17 | $149.2K | $0 | 4 | 2026-04-22 |
| HARROW, INC. (HROWM) Delisted | Director | — | $26.03 | — | $0 | 3 | 2025-06-24 |
| IVERIC bio, Inc. (ISEE) Delisted | Director | 22,088 | $39.95 | $882.4K | $0 | 6 | 2023-05-19 |
| AKORN INC (AKRX) Delisted | Director | 77,698 | — | — | -$392.7K | 8 | 2019-05-13 |
| IVERIC bio, Inc. (OPHT) Delisted | Director | — | — | — | $0 | 1 | 2018-12-14 |
| TearLab Corp (TEAR) Delisted | Director | — | — | — | $0 | 19 | 2016-06-28 |
| TearLab Corp (OCCX) Delisted | Director | — | — | — | $0 | 4 | 2007-07-05 |
Recent Filings
52 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-22 | HROW | Grant (A) | — | $0 | EDGAR |
| 2026-06-12 | OCUL | Grant (A) | +14,000 | $0 | EDGAR |
| 2026-05-19 | HROW | Buy (P) | +1,000 | $31.1K | EDGAR |
| 2026-04-22 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +24,367 | $0 | EDGAR |
| 2026-01-05 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +23,643 | $0 | EDGAR |
| 2025-06-24 | HARROW, INC. (HROWM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | OCUL | Grant (A) | +14,000 | $0 | EDGAR |
| 2025-05-02 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +79,504 | $0 | EDGAR |
| 2024-10-24 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-26 | OCUL | Grant (A) | +12,000 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.